Yield10 Bioscience (formerly Metabolix, Inc.) is a company developing new technologies to achieve improvements in crop yield to enhance global food security.
Oliver Peoples, Ph.D., and Anthony Sinskey, Ph.D., co-founded Metabolix after work at the (MIT) that identified the elementary methods and means for engineering polyhydroxyalkanoates production in plants and bacteria, thus making them biodegradable.
In 2019 Yield10 announced results from its 2018 field test, claiming that its C3003 gene trait showed an 11% increase in seed yield among canola crops, when compared to control plants.
In 2019, Yield10 filed a U.S. Patent application for new technology enabling low-cost production of PHA-based biomaterials, knowing for their use in water treatment to remove nitrogen and phosphates, to maintain the viability and vigor of Camelina seed.
[13] In 2018, Yield10 was granted a non-exclusive research license to CRISPR-Cas9 gene editing technology by DowDuPont’s agricultural business, Corteva Agriscience, and the non-profit Broad Institute of MIT and Harvard.